Dapar, Baby Boy .

HRN: 21-32-93  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2022
AMPICILLIN 500MG (VIAL)
05/13/2022
05/19/2022
IV
145mg
Q12
Non Institutional Delivery
05/13/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
05/13/2022
05/19/2022
IV
14.5mg
OD
Non Institutional Delivery
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: